Xeris Biopharma Holdings
XERS
XERS
236 hedge funds and large institutions have $611M invested in Xeris Biopharma Holdings in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 99 increasing their positions, 55 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.25% more ownership
Funds ownership: 60.76% → 61.01% (+0.25%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less capital invested
Capital invested by funds: $791M → $611M (-$180M)
Holders
236
Holding in Top 10
3
Calls
$5.19M
Puts
$3.37M
Top Buyers
| 1 | +$12.7M | |
| 2 | +$9.33M | |
| 3 | +$7.43M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.93M |
| 5 |
VC
Voss Capital
Houston,
Texas
|
+$6.73M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$7.62M | |
| 3 | -$4.77M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$4.32M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$3.73M |
